Several studies have demonstrated that TRIM31 can manipulate cancer-related genes or pathways, such as the TSC1-TSC2 complex, p52 (Shc), MMP2/9, p53-AMPK axis, NF-κB and PI3K/Akt pathways8,14,15,38–40. This evidence concerns the gene AKT1 and cancer.